Dr. Weis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11850 Blackfoot St NW
Minneapolis, MN 55433Phone+1 763-236-0808Fax+1 763-236-6065
Education & Training
- University of Utah HealthFellowship, Hematology and Medical Oncology, 1988 - 1991
- University of Utah HealthResidency, Internal Medicine, 1984 - 1987
- University of Minnesota Medical SchoolClass of 1984
Certifications & Licensure
- UT State Medical License 1985 - 2026
- MN State Medical License 2021 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 16 citationsPhase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first–line treatment of metastatic colorectal cancerG. Weldon Gilcrease, David D. Stenehjem, Mark Wade, John R. Weis, Kimberly McGregor
Investigational New Drugs. 2019-06-15 - 34 citationsMental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival.Shane Lloyd, David Baraghoshi, Randa Tao, Ignacio Garrido-Laguna, Glynn Weldon Gilcrease
American Journal of Clinical Oncology. 2019-04-01 - 31 citationsA Histone Methyltransferase ESET Is Critical for T Cell DevelopmentShoichi Takikita, Ryunosuke Muro, Toshiyuki Takai, Takeshi Otsubo, Yuki I. Kawamura
Journal of Immunology. 2016-09-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: